Returning to the pre-inflation shock level of over $80 means that BMY stock will have to gain more than 35% from here, and we think it will likely materialize over time.
Will Bristol Myers Squibb Stock Rebound To Its Pre-Inflation Shock Level Of $80? Forbes – Markets
